This cohort study investigates antibody waning after second and third doses of the BNT162b2 (BioNTech/Pfizer) COVID-19 vaccine. Click to show full abstract
This cohort study investigates antibody waning after second and third doses of the BNT162b2 (BioNTech/Pfizer) COVID-19 vaccine.
               
Click one of the above tabs to view related content.